TMSB4X

TMSB4X (Thymosin β4) is a regulator of actin cytoskeletal organization and cell biomechanics whose modulation alters cytoskeletal architecture, intermediate filament localization, and mechanical properties of cells (PMID:33807338). Through its cytoskeletal activity it negatively regulates dendrite morphogenesis, co-localizing with Crybb2 at actin-enriched cell ruffles and inhibiting dendritogenesis when overexpressed in hippocampal neurons (PMID:29864422). TMSB4X also acts in cell signaling and tissue remodeling: exogenous Tβ4 stabilizes HIF-1α by enhancing AKT-dependent phosphorylation and suppressing PHD expression, positioning it upstream of the PHD/FIH axis (PMID:34178995). In tumor contexts it engages succinylation-dependent interaction with TAGLN2 to promote glioma proliferation and migration (PMID:36131066), and it restrains the reprogramming of prostatic fibroblasts toward a cancer-associated phenotype while reducing fibroblast and co-cultured cancer cell migration (PMID:36169805). In immune regulation, TMSB4X promotes differentiation of mononuclear cells into dendritic cells and limits inflammatory and apoptotic responses (PMID:35932611). Its expression is androgen-dependent in reproductive tissue, being driven by testosterone in the epididymis (PMID:24039044). Beyond these contexts, the molecular details of how TMSB4X executes each role have not been further resolved in the available corpus.

1. 2013 Medium

   Established that TMSB4X expression is hormonally controlled, identifying androgen signaling as an upstream regulator of the gene in reproductive tissue.

   Evidence In vivo rat castration, Leydig cell ablation, and testosterone propionate rescue with expression readout

   PMID:24039044

   Open questions at the time

   • No identification of the transcription factors or androgen-responsive elements mediating regulation
   • Functional consequence of TMSB4X in epididymis not addressed
2. 2018 Medium

   Connected TMSB4X to neuronal morphogenesis, showing it acts at actin-rich structures to negatively regulate dendritogenesis in concert with Crybb2.

   Evidence Expression arrays in Crybb2-mutant brain, co-localization, and Tmsb4X overexpression in primary hippocampal neurons

   PMID:29864422

   Open questions at the time

   • Direct physical interaction between Tmsb4X and Crybb2 not demonstrated biochemically
   • Molecular mechanism linking actin sequestration to dendrite suppression unresolved
3. 2021 Medium

   Demonstrated that TMSB4X loss reorganizes the actin cytoskeleton and alters intermediate filament localization and cell stiffness, providing direct biomechanical evidence for its cytoskeletal role.

   Evidence Stable TMSB4X-silenced melanoma clones analyzed by atomic force microscopy, fluorescence imaging, and in vivo tumor formation

   PMID:33807338

   Open questions at the time

   • Mechanistic basis for Nestin/Vimentin relocalization not defined
   • Relationship between biomechanical changes and tumorigenicity not dissected
4. 2021 Medium

   Placed TMSB4X upstream of HIF-1α stabilization, defining a signaling role via AKT and the PHD/FIH oxygen-sensing axis distinct from its structural cytoskeletal function.

   Evidence Exogenous Tβ4 treatment of BMMSCs with pharmacological epistasis (YC-1, FG-4497) and Western blot for HIF-1α/p-HIF-1α

   PMID:34178995

   Open questions at the time

   • No receptor or direct binding partner linking extracellular Tβ4 to AKT identified
   • Whether the effect requires the actin-binding activity of TMSB4X is unknown
5. 2022 Medium

   Identified a succinylation-dependent TMSB4X–TAGLN2 interaction controlling glioma proliferation and migration, linking a post-translational modification to TMSB4X recruitment.

   Evidence Immunofluorescence co-localization and interaction assay comparing TAGLN2WT vs K40A mutant, with TMSB4X knockdown phenotypic rescue

   PMID:36131066

   Open questions at the time

   • Direct binding interface not mapped
   • Reciprocal validation of the interaction not shown
6. 2022 Medium

   Showed TMSB4X restrains cancer-associated fibroblast reprogramming and intercellular migration in the prostate tumor microenvironment, extending its role to stromal cell crosstalk.

   Evidence Retroviral TMSB4X overexpression in WPMY-1 fibroblasts co-cultured with PC3 cells; migration assays, CAF marker IF, CTAP-MS proteomics

   PMID:36169805

   Open questions at the time

   • Molecular pathway connecting TMSB4X to PDGFRB suppression unresolved
   • Secreted signals mediating cancer cell migration changes not identified
7. 2022 Medium

   Established TMSB4X as a promoter of dendritic cell differentiation that limits inflammation and apoptosis, defining an immunoregulatory function.

   Evidence Tmsb4x siRNA silencing and re-expression in LPS-stimulated mononuclear cells, flow cytometry, cytokine measurement, and mouse septicemia model

   PMID:35932611

   Open questions at the time

   • Molecular mechanism driving DC differentiation not defined
   • Direct targets of TMSB4X in this pathway unknown
8. 2024 Low

   Associated TMSB4X with hepatocellular carcinoma progression and ferroptosis suppression, broadening its tumor-promoting contexts.

   Evidence TMSB4X overexpression and knockdown in HCC cell lines with viability, invasion, and ferroptosis marker assays

   PMID:39556271

   Open questions at the time

   • No defined molecular mechanism for ferroptosis suppression
   • Single-lab phenotypic study without mechanistic validation
9. 2025 Low

   Identified TMSB4X as a downstream effector candidate of ABCA4 in AMPK-dependent mitophagy in lung adenocarcinoma.

   Evidence ABCA4 siRNA knockdown, RNA-seq for DEGs, Western blot for AMPK/mitophagy markers, pharmacological rescue, and electron microscopy

   PMID:40753852

   Open questions at the time

   • TMSB4X identified only as a downstream DEG with inferred interaction
   • Direct mechanistic role of TMSB4X not experimentally validated

• How TMSB4X's core actin-binding activity mechanistically connects its diverse context-specific roles in signaling, immunity, and tumor biology remains unresolved.
• No structural model linking actin sequestration to HIF-1α, dendritic, or immune functions
• Direct partners and recruitment mechanisms in most contexts uncharacterized